Literature DB >> 28440718

Problematizing the concept of the "borderline" group in performance assessments.

Matt Homer1, Godfrey Pell1, Richard Fuller1.   

Abstract

INTRODUCTION: Many standard setting procedures focus on the performance of the "borderline" group, defined through expert judgments by assessors. In performance assessments such as Objective Structured Clinical Examinations (OSCEs), these judgments usually apply at the station level. METHODS AND
RESULTS: Using largely descriptive approaches, we analyze the assessment profile of OSCE candidates at the end of a five year undergraduate medical degree program to investigate the consistency of the borderline group across stations. We look specifically at those candidates who are borderline in individual stations, and in the overall assessment. While the borderline group can be clearly defined at the individual station level, our key finding is that the membership of this group varies considerably across stations. DISCUSSION AND
CONCLUSIONS: These findings pose challenges for some standard setting methods, particularly the borderline group and objective borderline methods. They also suggest that institutions should ensure appropriate conjunctive rules to limit compensation in performance between stations to maximize "diagnostic accuracy". In addition, this work highlights a key benefit of sequential testing formats in OSCEs. In comparison with a traditional, single-test format, sequential models allow assessment of "borderline" candidates across a wider range of content areas with concomitant improvements in pass/fail decision-making.

Mesh:

Year:  2017        PMID: 28440718     DOI: 10.1080/0142159X.2017.1296563

Source DB:  PubMed          Journal:  Med Teach        ISSN: 0142-159X            Impact factor:   3.650


  1 in total

1.  Measuring the Effect of Using a Borderline Students' Characteristics Model on Reliability of Objective Structured Clinical Examination.

Authors:  Rabab A Abed; Shimaa E Elaraby
Journal:  Cureus       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.